Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of the JUICE HA® as an Anti-sarcopenia
Authors not listed
China Medical University Hospital · 2025
Abstract
This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Anonymous. (2025). Evaluation of the JUICE HA® as an Anti-sarcopenia. <em>China Medical University Hospital</em>. https://clinicaltrials.gov/study/NCT06950125
Vancouver
Anonymous. Evaluation of the JUICE HA® as an Anti-sarcopenia. China Medical University Hospital. 2025.
BibTeX
@misc{anon2025Evalua,
title = {Evaluation of the JUICE HA® as an Anti-sarcopenia},
author = {Anonymous},
journal = {China Medical University Hospital},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Taiwan University Hospital 2025
Open access · US-GOV
Improving Sarcopenia During Chemotherapy
Aventi Biotechnology Inc. 2022
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of AVTR101 in Sarcopenia Patients
Hanyang University Seoul Hospital 2023
Open access · US-GOV
12 Weeks, Randomized, Double-blind, Placebo-controlled Trial on the Efficacy and Safety of Kefir Whey Postbiotics
Hangzhou PhecdaMed Co., Ltd. 2026
Open access · US-GOV
A Randomized, Double-Blind, Multicenter, Placebo Parallel-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of TJ0113 Capsule in the Treatment of Patients With Sarcopenia
Hanyang University 2023
Open access · US-GOV
12 Weeks, Randomized, Double-blind, Placebo-controlled Trial on the Efficacy and Safety of Kefir Whey Postbiotics
Guangdong HuaPeptides Biotechnology Co., Ltd. 2023
Open access · US-GOV